Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis

被引：2

作者：

Ijichi, Hideaki ^{[1
]}

机构：

[1] Univ Tokyo, Tokyo, Japan

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 390卷 / 20期

关键词：

D O I：

10.1056/NEJMc2403986

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1934 / 1934

页数：1

共 2 条

[1] Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study [J].

Lammers, Willem J. ;

van Buuren, Henk R. ;

Hirschfield, Gideon M. ;

Janssen, Harry L. A. ;

Invernizzi, Pietro ;

Mason, Andrew L. ;

Ponsioen, Cyriel Y. ;

Floreani, Annarosa ;

Corpechot, Christophe ;

Mayo, Marlyn J. ;

Battezzati, Pier M. ;

Pares, Albert ;

Nevens, Frederik ;

Burroughs, Andrew K. ;

Kowdley, Kris V. ;

Trivedi, Palak J. ;

Kumagi, Teru ;

Cheung, Angela ;

Lleo, Ana ;

Imam, Mohamad H. ;

Boonstra, Kirsten ;

Cazzagon, Nora ;

Franceschet, Irene ;

Poupon, Raoul ;

Caballeria, Llorenc ;

Pieri, Giulia ;

Kanwar, Pushpjeet S. ;

Lindor, Keith D. ;

Hansen, Bettina E. .

GASTROENTEROLOGY, 2014, 147 (06) :1338-+

[2] Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases [J].

Lindor, Keith D. ;

Bowlus, Christopher L. ;

Boyer, James ;

Levy, Cynthia ;

Mayo, Marlyn .

HEPATOLOGY, 2019, 69 (01) :394-419

← 1 →